Skip to main content
SpringerLink
Log in

Managing Menstrual Irregularities in AID

  • Chapter
  • First Online:
Women's Health in Autoimmune Diseases

  • 406 Accesses

Abstract

Autoimmune rheumatological diseases (AIDs) can have a detrimental effect on a woman’s menstrual health and fertility prospects. The underlying pathophysiology is multi-factorial. The inflammatory milieu can suppress the hypothalamic-pituitary-gonadal axis, the co-existence of other autoimmune conditions such as primary hypothyroidism can play a role and the drugs used for the treatment of AIDs such as steroids and cyclophosphamide also have adverse effects pertaining to reproductive health. The work-up involves hormonal assessment and tests for ovarian reserve. Oral contraceptive pills can be used for restoring regularity of menstrual cycles, while steroid-sparing regimens and GnRH analogs have been used for ovarian function preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fatnoon NNA, Azarisman SMS, Zainal D (2008) Prevalence and risk factor for menstrual disorders among systemic lupus erythematosus patients. Singapore Med 49:413–418

    CAS  Google Scholar 

  2. Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II (2008) Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 26:436

    CAS  PubMed  Google Scholar 

  3. Harvey AM, Shulman LE, Tumulty PA et al (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33:291

    Article  CAS  Google Scholar 

  4. Wallace DJ, Dubois EL (eds) (1987) Dubois’ lupus erythematosus, 3rd edn. Lea & Febiger, Philadelphia, PA

    Google Scholar 

  5. Rivest S, Rivier C (1993) Central mechanisms and sites of action involved in the inhibitory effects of CRF and cytokines on LHRH neuronal activity. Ann N Y Acad Sci 697:117–141

    Article  CAS  Google Scholar 

  6. Kalra PS, Edwards TG, Xu B, Jain M, Kalra SP (1998) The antigonadotropic effects of cytokines: the role of neuropeptides. Domest Anim Endocrinol. 15:321–332

    Article  CAS  Google Scholar 

  7. Rivier C, Vale W (1990) Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology 127:849–856

    Article  CAS  Google Scholar 

  8. Watanobe H, Hayakawa Y (2003) Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology 144:4868–4875

    Article  CAS  Google Scholar 

  9. Yoo MJ, Nishihara M, Takahashi M (1997) Tumor necrosis factor-alpha mediates endotoxin induced suppression of gonadotropin-releasing hormone pulse generator activity in the rat. Endocr J 44:141–148

    Article  CAS  Google Scholar 

  10. Russell SH, Small CJ, Stanley SA, Franks S, Ghatei MA, Bloom SR (2001) The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic–pituitary gonadal axis. J Neuroendocrinol 13:296–301

    Article  CAS  Google Scholar 

  11. Pasoto SG, Mendonça BB, Bonfá EF (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11:175–180

    Article  CAS  Google Scholar 

  12. Ferrari SM, Elia G, Virili C, Centanni M, Antonelli A, Fallahi P (2017) Systemic lupus erythematosus and thyroid autoimmunity. Front Endocrinol (Lausanne) 8:138. Published 19 Jun 2017. https://doi.org/10.3389/fendo.2017.00138

    Article  Google Scholar 

  13. Blanco-Favela F, Quintal MG, Chavez-Rueda AK, Leanos-Miranda A, Berron-Peres R, Baca-Ruiz V, Lavalle-Montalvo C (2001) Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients. Lupus 10:803–808

    Article  CAS  Google Scholar 

  14. Edens C, Antonelli M (2017) Polycystic ovarian syndrome in rheumatic disease [Internet]. ACR Meeting Abstracts. Available from: https://acrabstracts.org/abstract/polycystic-ovarian-syndrome-in-rheumatic-disease/

  15. Ma W, Zhan Z, Liang X et al (2013) Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy. J Womens Health 22:1023–1027

    Article  Google Scholar 

  16. Ulug P, Oner G, Kasap B et al (2014) Evaluation of ovarian reserve tests in women with systemic lupus erythematosus. Am J Reprod Immunol 72:85–88

    Article  CAS  Google Scholar 

  17. Pasoto SG, Viana VS, Mendonca BB et al (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 26:1087–1093

    CAS  PubMed  Google Scholar 

  18. Holley JL, Schmidt RJ (2013) Changes in fertility and hormone replacement therapy in kidney disease. Adv Chronic Kidney Dis 20:240–245

    Article  Google Scholar 

  19. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M (2000) Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 9:401–405

    Article  CAS  Google Scholar 

  20. Huong DL, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29:2571–2576. Epub 5 Dec 2002

    CAS  PubMed  Google Scholar 

  21. Park MC, Park YB, Jung SY, Chung IH, Choi KH, Lee SK (2004) Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus 13:569–574

    Article  CAS  Google Scholar 

  22. Mattinson DR, Nightingale MS, Shiromizu K (1983) Effects of toxic substances on female reproduction. Environ Health Perspect 48:43–52

    Article  Google Scholar 

  23. Boumpas DT, Austin HA 3rd, Vaughan EM et al (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366

    Article  CAS  Google Scholar 

  24. de Araujo DB, Yamakami LY, Aikawa NE et al (2014) Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol 43:503–511

    Article  Google Scholar 

  25. McLaren JF, Burney RO, Milki AA et al (2009) Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation. Fertil Steril 92:515–519

    Article  CAS  Google Scholar 

  26. Centers for Disease Control and Prevention (2010) U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Morb Mortal Wkly Rep 59:1–86

    Google Scholar 

  27. Clowse ME, Behera MA, Anders CK et al (2009) Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 18:311–319. Epub 14 Mar 2009

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Rama Walia & Anshita Aggarwal

Authors
  1. Rama Walia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anshita Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, PGIMER, Chandigarh, India

    Shefali Khanna Sharma

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Walia, R., Aggarwal, A. (2020). Managing Menstrual Irregularities in AID. In: Sharma, S. (eds) Women's Health in Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-0114-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0114-2_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0113-5

  • Online ISBN: 978-981-15-0114-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation